This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit August 06, 2014



















Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.


 


PHARMACY UPDATES

US government working with drug company to develop treatment for Ebola
Forbes
A top U.S. biological-warfare unit is developing a cure for the deadly Ebola virus and could have it in the field within two years. The virus, which has killed more than 800 people in West Africa as of Aug. 4, is a "Category A Bioterrorism Agent" along with anthrax, botulism, bubonic plague and smallpox, according to the U.S. Centers for Disease Control.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Pharmacists adopt prescription 'synching'
Brattleboro Reformer
Some people have multiple prescriptions, and keeping track of all them — when they need to be refilled and when they need to be taken — can be confusing and for some of those people, losing track of their prescriptions could endanger their health. Pharmacists around the nation are attempting to address this situation with something called prescription synchronization.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword PRESCRIPTION.


Experimental drug likely saved Ebola patients
CNN
Three vials containing an experimental drug stored at subzero temperatures were flown into Liberia recently in a last-ditch effort to save two American missionary workers who had contracted Ebola, according to a source familiar with details of the treatment. The drug appears to have worked, sources say. Dr. Kent Brantly's and Nancy Writebol's conditions significantly improved after receiving the medication, sources say.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE



IN THE NEWS


California pharmacy board delays action on translating drug labels
The Sacramento Bee
The California State Board of Pharmacy steered away July 31 from a decision on whether pharmacies should be required to translate prescription drug labels for limited-English speakers and passing the issue to another committee for further discussion.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Be a part of Innovation!

Banner Pharmacy Services will be recognized nationally as a clinical leader and trusted partner in providing innovative pharmacy services and coordinated patient care through convenient access and improved medication outcomes across the continuum.

Click here for Leadership opportunities

Contact: shaun.gustafson@bannerhealth.com
 


Prescription drug addiction: Stemming an epidemic
The Legal Examiner
If you take a look at Google News, you're likely to see a plethora of stories related to the crimes and woes related to prescription drug addiction. It's typically the powerful prescription painkillers, hydrocodone, oxycodone and methadone responsible for the uptick in prescription drug addictions and related deaths. These drugs, known as opioid painkillers, were prescribed at an astonishing rate in 2012 alone. Centers for Disease Control statistics show that a total of 259 prescriptions were written that year, which is enough for every American to have a bottle at their disposal.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Some vaccines need to be repeated; others should be initiated during adulthood
The Washington Post
You might think that the shots you received as a child to protect you from tetanus, diphtheria and more would last a lifetime. Not so. Certain vaccines need to be repeated during adulthood to ensure that you stay protected, while others, such as the rubella vaccine and chickenpox shot, weren't even around when many of us were young.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
More research needed on medication management in dementia
Medical Xpress
Family carers of people with dementia need more help with medication management according to a new report involving the University of East Anglia, which was led by the University of Aston. Researchers interviewed family members who care for loved ones with dementia to find out more about the problems they face.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Ebola outbreak: Is it time to test experimental vaccines?
CNN
Ebola virus disease is sweeping across West Africa in the largest outbreak of the virus to date. Mortality rates are currently at 60 percent in a disease where up to 90 percent of infected people can die. But despite this lethality there remain no licensed treatments or vaccines available, nearly 40 years after the disease was first discovered.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MEDICATION UPDATES


Stop whining: Insurers and the high price hype of Hepatitis C
By Jason Poquette
There has been a lot of fuss in the media over the price of the newest treatment options for Hepatitis C, a condition affecting around 3 million Americans. Sovaldi by Gilead costs $84,000 for a 12-week course of therapy. Their competitor Olysio by Janssen comes in around $66,000 for the same 12 weeks. This high price tag has caused many players in the market to moan and cry, particularly the insurance companies who have to come up with ways to pay the bill.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




HIV medication delivered through dissolvable fabric could provide faster protection
The Medical Daily
A new dissolvable fabric could pave the way for faster, more efficient delivery of the HIV medicine, maraviroc. Published in the journal Antimicrobial Agents and Chemotherapy, the study suggests a method of HIV protection that avoids messy gels or cream, with the added benefit of stronger potency.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Olodaterol approved for COPD
ASHP
FDA and Boehringer Ingelheim announced the approval of olodaterol oral inhalation spray as a long-term, once-daily maintenance bronchodilator to relieve airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Pharmacists fighting tobacco use? CDC launches website targeted at most accessible provider (Pharmacy Times)
Dextromethorphan abuse: A common choice for addicts of all ages (By Cynthia Sheppard Solomon)
FDA reviewing what could be first biosimilar drug (The Associated Press via ABC News)
FedEx charges raise questions about shipping industry's role in scrutinizing online pharmacies (The Associated Press via The Ottawa Citizen)

Don't be left behind. Click here to see what else you missed.


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Assistant Executive Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
July 30. 2014
July 23, 2014
July 16, 2014
July 9, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063